Alkermes plc. (ALKS)
Alkermes plc. (ALKS) is a Healthcare stock tracked by StreetAlpha. ALKS reports earnings on Wed, Oct 28, 2026. Analyst consensus is Buy, based on the latest ratings from 6 firms (3 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ALKS, 0% of them bullish and 100% bearish. In the past 30 days there were 2 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 24 | Goldman Sachs | Reinstated | Hold | — |
| Sep 22 | Baird | Target raised | Buy | — |
| Aug 16 | HC Wainwright & Co. | Reiterated | Hold | — |
| Jul 29 | JP Morgan | Target raised | Hold | — |
| Jul 29 | Baird | Maintained | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALKS is in one of them and how their past ALKS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ALKS in an article yet. Here's the latest on the wider market.
ALKS Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Sep 29, 2026 | Oct 13, 2026 | 14 d |
| Donald J TrumpExecutive branch | Sell | $50K – $100K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Gilbert CisnerosD · CA | Buy | $15K – $50K | Jul 30, 2026 | Sep 4, 2026 | 36 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.